165 related articles for article (PubMed ID: 16254324)
21. Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II fcgamma receptor (CD32).
Palmer P; Charley B; Rombaut B; Daëron M; Lebon P
Virology; 2000 Dec; 278(1):86-94. PubMed ID: 11112484
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
[TBL] [Abstract][Full Text] [Related]
23. Using IFN-gamma as a biomarker for detecting exposure to viral pathogens.
Li L; Dufour AP
Curr Microbiol; 2008 Jan; 56(1):84-8. PubMed ID: 17926092
[TBL] [Abstract][Full Text] [Related]
24. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein.
Chieux V; Chehadeh W; Harvey J; Haller O; Wattré P; Hober D
Virology; 2001 Apr; 283(1):84-92. PubMed ID: 11312665
[TBL] [Abstract][Full Text] [Related]
26. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
[TBL] [Abstract][Full Text] [Related]
27. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
[TBL] [Abstract][Full Text] [Related]
28. [Demonstration and immunologic effect of an infection of the human thymus by the diabetogenic human Coxsackievirus B4].
Brilot F
Bull Mem Acad R Med Belg; 2003; 158(5-6):277-83. PubMed ID: 15025268
[TBL] [Abstract][Full Text] [Related]
29. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
[TBL] [Abstract][Full Text] [Related]
30. [The effects of inoculation route and adjuvant type on the immunizing potency of CVB3 VP1 protein].
Wen C; Gao ZY; Lan JM; Yan LJ; Chuai X; Li J; Li W; Wang YX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1086-9. PubMed ID: 21968309
[TBL] [Abstract][Full Text] [Related]
31. Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA.
Alidjinou EK; Chehadeh W; Weill J; Vantyghem MC; Stuckens C; Decoster A; Hober C; Hober D
Eur J Clin Invest; 2015 Sep; 45(9):918-24. PubMed ID: 26108863
[TBL] [Abstract][Full Text] [Related]
32. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
[TBL] [Abstract][Full Text] [Related]
33. Reconstituted coronavirus TGEV virosomes lose the virus ability to induce porcine interferon-alpha production.
Riffault S; Grosclaude J; Vayssier M; Laude H; Charley B
Vet Res; 1997; 28(1):77-86. PubMed ID: 9172843
[TBL] [Abstract][Full Text] [Related]
34. Low levels of mumps virus antigen induced interferon-alpha production in insulin-dependent diabetes.
Ilonen J; Salonen R; Salmi A; Mustonen A
Diabetes Res; 1989 Oct; 12(2):75-8. PubMed ID: 2561352
[TBL] [Abstract][Full Text] [Related]
35. [The effect of interleukin-7 and interleukin-15 on the production of Th1 and Th2 cytokines by peripheral blood mononuclear cells from patients with tuberculosis].
Yang XM; Dong DQ; Li C; Yang YH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):403-6. PubMed ID: 17045026
[TBL] [Abstract][Full Text] [Related]
36. Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication.
Yen MH; Lee JJ; Yeh CF; Wang KC; Chiang YW; Chiang LC; Chang JS
J Ethnopharmacol; 2014 Feb; 151(3):1056-1063. PubMed ID: 24361333
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes.
Varela-Calvino R; Ellis R; Sgarbi G; Dayan CM; Peakman M
Diabetes; 2002 Jun; 51(6):1745-53. PubMed ID: 12031961
[TBL] [Abstract][Full Text] [Related]
38. Persistent infection of a carcinoma thyroid cell line with coxsackievirus B.
Desailloud R; Sané F; Caloone D; Hober D
Thyroid; 2009 Apr; 19(4):369-74. PubMed ID: 19292692
[TBL] [Abstract][Full Text] [Related]
39. Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses.
Lasrado N; Arumugam R; Rasquinha MT; Sur M; Steffen D; Reddy J
Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835449
[TBL] [Abstract][Full Text] [Related]
40. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
